Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Decitabine in Colon Cancer: Proof-of-principle Study
2013-001060-38Phase 2Terminated
- Sponsor
- Academic Medical Center
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of decitabine in colon cancer, sponsored by Academic Medical Center. Primary endpoint: Wnt target gene expression. Started Apr 2013; status: terminated.
02
Drugs
decitabine
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2013-001060-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001060-38.